We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Allergan plc | NYSE:AGN | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
From May 2019 to May 2024
By Rob Copeland
Bill Ackman's Pershing Square L.P. hedge fund returned 25% in the first half of the year, according to an investor update, helped by the activist investor's backing of a hostile takeover bid for Botox maker Allergan Inc.
By comparison, the S&P 500 index climbed more than 6% during the 2014 first half.
New York-based Pershing Square rose 2.4% in June, the update indicated. Overall, Pershing Square Capital Management LP now manages $14.7 billion.
Mr. Ackman, known for taking large, concentrated bets, has been even more outspoken that usual this year in backing Valeant Pharmaceuticals International Inc.'s bid for Allergan. His firm also continues to criticize nutritional supplements maker Herbalife Ltd., which Pershing Square believes is a pyramid scheme. Herbalife has denied the accusation.
A Pershing spokeswoman wasn't immediately available for comment.
Write to Rob Copeland at rob.copeland@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
